Kinney Drugs 因数百起客户投诉撤回人工智能电话助手
Kinney Drugs pulls back AI phone assistant after hundreds of customer complaints

原始链接: https://www.wcax.com/2026/08/07/kinney-drugs-pulls-back-ai-phone-assistant-after-hundreds-customer-complaints/

Kinney Drugs 正在缩减其人工智能助手“Burt”的使用规模,此前该系统因技术故障引发了广泛的客户投诉。自五月份推出以来,据报道该系统不仅提供前后矛盾的信息和错误的药物剂量,还未能及时发送处方通知。 针对此次负面反响,Kinney Drugs 总裁 John Marraffa 表示,尽管公司将 HIPAA 合规性和数据安全放在首位,但未能提供良好的用户体验。因此,药房已恢复使用传统的按键式电话系统来处理呼入的患者来电。 尽管客户对个人健康信息的隐私表示担忧,但 Marraffa 重申该人工智能系统是安全的,不会篡改数据。尽管遭遇了挫折,Kinney 仍将继续使用 Burt 发送处方续配的自动短信通知,但该服务现已改为由患者自主选择加入。

在收到数百起客户投诉后,Kinney Drugs 撤下了其人工智能电话助理。这一事件凸显了企业削减成本与消费者服务质量之间日益加剧的矛盾。 批评人士认为,企业正越来越多地利用人工智能作为一道“防御层”,以阻碍客户联系人工客服。这种做法实际上制造了一个“问责黑洞”,使医疗等关键服务变得复杂化。尽管支持者认为人工智能可以缩短等待时间并高效处理常规咨询,但用户和行业专家强调,药房业务涉及药物、保险和健康问题,目前的 AI 模型尚无法处理此类复杂事项。 Hacker News 上的讨论表明,许多人工智能应用的失败,是因为它们缺乏必要的领域专业知识,且难以处理偏离标准脚本的“长尾”问题。此外,评论者指出,企业往往优先考虑“廉价”方案而非功能性方案,迫使客户陷入令人沮丧、循环往复且无法解决实际问题的沟通中。这导致许多人认为,客户服务中的人工智能并非技术进步,而是一种倒退,它不仅削弱了信任,还伤害了那些依赖个性化、可靠沟通来满足健康需求的弱势群体。
相关文章

原文

BURLINGTON, Vt. (WCAX) - Kinney Drugs is scaling back its AI assistant after customers reported incoherent calls, wrong dosages, and missed prescription notifications.

Kinney Drugs first introduced Burt, an AI assistant named after the pharmacy chain’s founder, back in May. The bot’s role was to communicate with patients about prescriptions and refills. But customers quickly reported a number of issues with the tech, as first reported by VTDigger.

“But one thing I want to point out is getting privacy and security right does not mean we got the experience right. We did not, and we own that,” Kinney Drugs President John Marraffa said.

Marraffa says Kinney will return to its old model for incoming patient calls — the classic touch-tone phone system.

Customers also raised concerns about data privacy — worried their personal health information could be exposed through an AI platform. Marraffa says Burt is fully HIPAA compliant and that the AI is not open-source and does not generate or manipulate data.

Kinney will keep Burt for outbound communications like prescription refill texts, but patients must opt in to receive them.

Copyright 2026 WCAX. All rights reserved.

联系我们 contact @ memedata.com